Skip to content
Skyepharma
  • About-us
  • Services
    • Research and Development
    • Manufacturing
    • Packaging
    • Project management
  • Technologies
    • Modified release technologies
    • Innovation pipeline
  • Key differenciators
    • Highly Potent API
    • Non Sexual Hormones
    • Bioproduction
    • API combination
  • Articles
English
  • Français
Skyepharma
  • About-us
  • Services
    • Research and Development
    • Project management
    • Manufacturing
    • Packaging
  • Technologies
    • Modified release technologies
    • Innovation pipeline
  • Key differenciators
    • Non Sexual Hormones
    • Highly Potent API
    • Bioproduction
    • API combination
  • Articles
  • English
    • English
    • Français
  • About-us
  • Services
    • Research and Development
    • Project management
    • Manufacturing
    • Packaging
  • Technologies
    • Modified release technologies
    • Innovation pipeline
  • Key differenciators
    • Non Sexual Hormones
    • Highly Potent API
    • Bioproduction
    • API combination
  • Articles
  • English
    • English
    • Français
English
  • Français

Our articles

Welcome to our CDMO news plateforme !

Discover and follow our latest updates and learn about our scientific expertise. 

Buccal drug

Targeting Rapid Response: Our Buccal Permeability Platform for Emergency Drugs

Read the article »
Mucotabs 2

The MucoTabs Project: Targeting the GI Tract with Mucoadhesive Oral Tablets

Read the article »
pharma development

5 Reasons Pharma Is Outsourcing HPAPI and Complex Dosage Forms to European CDMOs

Read the article »
Project management at Skyepharma

Managing Right First Time from the ground up at Skyepharma

Read the article »
Press-Coated Tablets

Controlling the lag-time and release kinetics of press-coated tablets using process parameters and tablet geometry

Read the article »
Team Eneapharm and Skyepharma

Collaboration Eneapharm & Skyepharma

Read the article »
Formulation design

Rush Now and Regret Later or the Importance of Getting the Formulation Strategy Right from the Start

Read the article »
New FlexiPack Line

4 Reasons Why Orphan Drugs Require a Specific Packaging Line

Read the article »
lagepp

MucoTabS Reaches a Key Milestone with Official Patent Filing

Read the article »
Nouvelle-direction-Skye

Skyepharma : The French CDMO Advances Strategic Growth Through Leadership and Shareholder Transition

Read the article »
scientific symposium

Skyepharma Scientific Symposium 2025: “Advances in Overcoming Oral Dosage Form Development Challenges”.

Read the article »

Suscribe to our newsletter

Skyepharma

Expert and innovative CDMO, specialist of oral solid forms from development to manufacturing

Linkedin Youtube
Services
  • Development
  • Manufacturing
  • Packaging
  • Regulatory support
  • Innovation
Other Links
  • Supply chain
  • Whistleblowing reporting
  • Terms and Conditions
  • Privacy and Cookie Policy
  • Pharmacovigilance
Get In Touch

55 Rue du Montmurier, 38070 Saint-Quentin-Fallavier

Tél.: +33 4 74 95 20 20

© 2026 All Rights Reserved.

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
Le stockage ou l’accès technique qui est utilisé exclusivement à des fins statistiques. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}